// App-Quantinova.ai

: Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine)

Researchers

Presenter

  • Roberto Walter Dal Negro

Principal Investigators

  • Jadwiga A. Wedzicha

  • Martin Iversen Iversen

  • Giovanni Fontana

  • Clive Page

  • Arrigo F. Cicero

  • Edoardo Pozzi

  • Peter M.A. Calverley

Medical Centers

  • National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy

  • Airway Disease Infection Section, National Heart and Lung Institute (NHLI), Imperial College London, London, United Kingdom.

  • Division of Lung Transplantation, Rigshospitalet, University Hospital, Copenhagen, Denmark

  • Pulmonology Department, Cough Center, Careggi University Hospital, Firenze, Italy

  • Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College , London, United Kingdom

  • Medical and Surgical Department, University of Bologna, Bologna, Italy

  • Medical Affairs Department, Masate, Italy

  • Clinical Sciences Centre, University Hospital , Aintree, United Kingdom

Locations

  • Italy

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Erdosteine

  • Proglumide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

  • Parallel Group

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved